- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Fuji introduces Synapse Simplicity
For low-volume medical centers that need networking, Synapse Simplicity is the answer, according to its developer, Fujifilm Medical Systems USA. Synapse Simplicity is an economical version of the company's Synapse PACS. The product, unveiled at the HIMSS
For low-volume medical centers that need networking, Synapse Simplicity is the answer, according to its developer, Fujifilm Medical Systems USA. Synapse Simplicity is an economical version of the company's Synapse PACS. The product, unveiled at the HIMSS meeting, can handle 60,000 procedures annually. A complete package configuration could include diagnostic or clinical workstations, a multifunctional PACS server, DVD high-speed robotic archiving, and professional installation and integration services. Because Simplicity uses the same hardware and software components as Fuji's community and enterprise PACS offerings, the system can expand to meet changing facility needs. The new package joins two other Fuji products designed specifically for low-volume imaging facilities, SmartCR and the DryPix 1000 dry imager.
2/28/01, Issue # 1504, page 4.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
